Standout Papers

Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Canc... 2003 2026 2010 2018 2.8k
  1. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (2005)
    Scott A. Tomlins, Daniel R. Rhodes et al. Science
  2. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells (2003)
    Celina G. Kleer, Qi Cao et al. Proceedings of the National Academy of Sciences
  3. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer (2016)
    Himisha Beltran, Davide Prandi et al. Nature Medicine
  4. Prostate cancer (2015)
    Gerhardt Attard, Chris Parker et al. The Lancet
  5. Integrative molecular concept modeling of prostate cancer progression (2006)
    Scott A. Tomlins, Rohit Mehra et al. Nature Genetics
  6. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression (2005)
    Sooryanarayana Varambally, Jianjun Yu et al. Cancer Cell
  7. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (2007)
    Scott A. Tomlins, Bharathi Laxman et al. Nature
  8. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer (2008)
    Scott A. Tomlins, Bharathi Laxman et al. Neoplasia
  9. Recurrent gene fusions in prostate cancer (2008)
    Chandan Kumar‐Sinha, Scott A. Tomlins et al. Nature reviews. Cancer
  10. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment (2015)
    Scott A. Tomlins, John Day et al. European Urology

Immediate Impact

8 by Nobel laureates 17 from Science/Nature 71 standout
Sub-graph 1 of 20

Citing Papers

Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives
2023 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
7 intermediate papers

Works of Scott A. Tomlins being referenced

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer
2022
Prostate cancer
2015 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Scott A. Tomlins 11236 11658 6651 261 22.1k
Jack A. Schalken 8788 9475 4984 407 19.2k
John T. Isaacs 8237 10768 3557 303 21.0k
Lawrence D. True 7850 5980 3198 275 15.6k
Robert L. Vessella 13934 17044 11652 314 31.3k
Yoshitaka Fujii 8943 7574 3917 436 19.6k
Arul M. Chinnaiyan 8679 13986 6133 110 21.7k
Lukas Bubendorf 6303 8177 3911 317 17.1k
Sooryanarayana Varambally 9544 18701 8321 154 26.4k
Michael F. Berger 4928 7242 4999 317 16.7k
Christopher J. Logothetis 9469 6778 3574 448 20.4k

All Works

Loading papers...

Rankless by CCL
2026